To test the hypothesis that fetal vessel inflammation (FVI: funisitis and/or fetal vasculitis) is associated with lower blood pressure (BP) over the first week of life and an increased risk of periventricular leukomalacia (PVL) among premature infants.
INTRODUCTION
Periventricular leukomalacia (PVL) has been attributed to both hypoxia-ischemia 1, 2 and to cytokine-mediated inflammation in the context of chorioamnionitis. 3, 4 These two mechanisms may not be mutually exclusive. We have shown previously that even in the absence of bacteremia, premature infants born after chorioamnionitis had lower blood pressure (BP) in the first few hours of life than did infants born preterm without chorioamnionitis. 5 In that cohort, BP measured at 3±1 hours after birth was inversely correlated with cord blood interleukin-6 concentration. 5 Since cytokines are known mediators of ''septic shock'', 6 we speculated that cytokines produced in the fetus and the premature newborn in the context of chorioamnionitis 3,5 mediate systemic hemodynamic changes that then predispose these infants to periventricular white matter ischemia.
Inflammation of the umbilical cord (funisitis) and/or fetal blood vessels on the placental plate (fetal vasculitis) occurs in association with higher grades of chorioamnionitis. Such an inflammatory response in the fetal vessels may signify a systemic vascular inflammation within the fetus itself, and thus may be a marker for newborns who will be more likely to exhibit hypotension, and are thereby at increased risk for PVL. Yet, the relationship between fetal vessel inflammation (FVI), BP, and PVL has not been defined for very-low-birth-weight infants.
In this study, we tested the hypothesis that very-low-birth-weight infants with placental evidence of FVI have lower BP over the first week of life, and an increased likelihood of white matter injury than do infants without placental evidence of FVI.
MATERIALS AND METHODS Study Design
This study was approved by the Institutional Review Board of Magee-Womens Hospital.
A retrospective medical record review was conducted for infants with birth weight <1350 g born between July 1, 1997 and June 30, 2000 who were admitted to the neonatal intensive care unit (NICU) at Magee-Womens Hospital (Pittsburgh, PA, USA) within 12 hours of birth. Infants were included if they survived for at least 1 week, had BP data recorded in the medical record for each of the first 7 days of life, and had both placental histopathology and at least one cranial ultrasound performed. Exclusion criteria included congenital anomalies of the brain, heart, or kidneys; hydrops fetalis; and twin-to-twin transfusion sequence. In addition, infants born to mothers with pre-eclampsia were excluded because we have shown that these infants may have elevated BP in the first week of life. 7 BP in the immediate newborn period is tightly correlated with gestational age (GA). 8 Thus, infants were placed into one of three GA stratum: 23 to 26, 27 to 29, and Z30 weeks based on the best estimate of GA. Obstetrical dating was used if an ultrasound was obtained prior to 18 weeks gestation or if the date of the last menstrual period was known. The neonatal (revised Ballard Score) 9 assessment was used by clinicians when reliable obstetric dating was not available.
BP Data Collection
For each of the first 7 days of life, the lowest mean arterial BP (LoBP mn ) was recorded along with the corresponding systolic (LoBP sys ) and diastolic (LoBP dia ) BPs. On the same days, the highest systolic BP (HiBP sys ) and corresponding mean (HiBP mn ) and diastolic (HiBP dia ) BPs were also recorded.
Day-specific ranges for systolic, mean, and diastolic BP were constructed within each GA stratum using data collected from the entire population of infants <1350 g without congenital anomalies admitted to the NICU in the same time period. Hypotension was diagnosed when the lowest mean arterial BP was below the 25th percentile for GA stratum on a given day. Persistent hypotension was defined as 3 or more days with LoBP mn below the 25th percentile for GA stratum and day-specific range.
Umbilical arterial line BP were recorded preferentially. Dynamap s BPs were used when invasive monitoring was not available, and were considered acceptable since they have been shown to correlate well with intra-arterial BP monitoring. 10, 11 Placental Histopathology The diagnoses of chorioamnionitis and FVI were adapted from the criteria recommended by the Perinatal Section of the Society for Pediatric Pathology. 12 Chorioamnionitis was defined as the presence of neutrophils in the fibrous amnion and/or chorion, irrespective of severity grade. FVI was defined as a fetal inflammatory response with chorionic vasculitis (intramural polymorphonuclear cells in the chorionic vessels), umbilical phlebitis (intramural polymorphonuclear cells in the umbilical vein), and umbilical vasculitis of one or two arteries, irrespective of severity grade, and the presence of chorioamnionitis.
Cranial Ultrasonography
All cranial ultrasounds were interpreted by a pediatric radiologist, and the most severe abnormality noted. Cystic PVL was defined as the presence of echolucencies >1 mm in the periventricular white matter at any time. Ventriculomegaly was diagnosed if enlarged ventricles were found in the absence of intraventricular blood. For the purposes of this investigation, we classified infants as having white matter injury if either cystic PVL or ventriculomegaly were reported. Transient increased echogenicity in the periventricular white matter without subsequent cyst formation or subsequent ventriculomegaly was not considered to represent white matter injury.
Statistical Analysis
Within each GA stratum, repeated measures ANOVA was used to compare BPs between infants with and without FVI, with and without histologic evidence of chorioamnionitis, and with and without PVL. The model used included day as the repeated factor, the method of BP measurement, and an interaction term between day and FVI, day and chorioamnionitis, or day and PVL, as appropriate. After the primary analysis was completed, the analysis was repeated with the addition of antenatal steroid administration as a cofactor. w 2 analysis was used to compare demographic variables and the prevalence of PVL between infants in each histologic group. Fisher's exact test was used where n<5. Binomial logistic regression was used to test predictors of white matter injury among infants.
RESULTS

Demographic and Clinical Variables
Demographic and clinical characteristics are given in Table 1 . Within each GA stratum, infants with and without FVI had similar birth weight, 5-minute Apgar score, need for cardiopulmonary resuscitation or ventilation at birth, incidence of respiratory distress syndrome, and receipt of antenatal glucocorticoid. Male gender was less common among infants with FVI in the 23 to 26 week ( p ¼ 0.007) and the 27 to 29 week ( p ¼ 0.015) GA strata.
The incidence of pregnancy complications that prompted the preterm delivery differed between infants with and without FVI ( Table 1 ). The diagnosis of chorioamnionitis was made on clinical grounds more often in mothers whose infants had FVI than in mothers whose infants did not have fetal vessel inflammation in the 27 to 29 week gestation stratum only. However, histologic evidence of chorioamnionitis was found among infants without FVI in all GA strata (23 to 26 weeks: 14/47 (30%), 27 to 29 weeks: 16/65 (25%), Z30 weeks: 2/20 (10%)).
Volume resuscitation was given at similar rates to infants with and without FVI ( Table 1) . Data regarding vasopressor administration was available for 89% of the infants. Of these, vasopressors were used in 25% of infants born at 23 to 26 weeks, 10% of infants born at 27 to 29 weeks, and none of the infants Z30 weeks gestation. Vasopressor use was similar for infants with out without FVI in the youngest GA stratum. For infants born at 27 to 29 weeks gestation, vasopressors were used only in infants without FVI.
BP and FVI
Among infants of all GA, BP increased from day 1 to day 7 of life (ANOVA, p<0.0001). HiBP sys , HiBP mn, and HiBP dia as well as LoBP sys , LoBP mn , and LoBP dia did not differ between infants with and without FVI at either 23 to 26 or 27 to 29 weeks gestation. Among infants born after 29 weeks gestation, FVI was associated with lower HiBP sys , HiBP mn, and HiBP dia (Figure 1a ; ANOVA p ¼ 0.0000, 0.0002, and 0.0003, respectively), and with lower LoBP sys , LoBP mn , and LoBP dia (Figure 1b ; ANOVA p ¼ 0.0012, p<0.0001, and p ¼ 0.0005, respectively).
Infants born at 23 to 26 and 27 to 29 weeks gestation with and without FVI were equally likely to have hypotension on the first day of life (27 vs 26% and 24 vs 30%, respectively). For infants of 27 to 29 weeks gestation, persistent hypotension was found to be less common among infants with FVI than without FVI (3/ (LoBP sys , LoBP mn , and LoBP dia ) were all significantly lower in infants exposed to chorioamnionitis than in unexposed infants (ANOVA p ¼ 0.0004, p<0.0000, and p ¼ 0.0001, respectively).
Effect of Exposure to Antenatal Steroid
The majority of infants born at r29 weeks gestation were exposed to antenatal steroid, precluding a reliable analysis of the effect of antenatal steroid administration on these young infants. For infants in the Z30-week stratum, the number of infants exposed to antenatal steroid was not significantly different between infants with and without FVI (w 2 p ¼ 0.127). However, since 22% of all infants in this GA stratum were not exposed to antenatal steroid, the effect of this therapy could be analyzed reliably.
For infants born at Z30 weeks gestation, antenatal steroids had an independent effect on BP, with higher HiBP sys , HiBP mn, HiBP dia , LoBP sys , LoBP mn , and LoBP dia (ANOVA, p ¼ 0.0034, 0.03, 0.0082, 0.02, 0.0025, and 0.0019, respectively). However, all six BP variables remained significantly lower among infants with FVI when antenatal steroids were included in the ANOVA model (p ¼ 0.002, 0.006, 0.004, 0.021, 0.0000, and 0.010 for HiBP sys , HiBP mn, HiBP dia , LoBP sys , LoBP mn , and LoBP dia , respectively).
Cranial Ultrasound Evidence of White Matter Injury
Cystic PVL was diagnosed in five (2.4%) infants. Infants with PVL ranged in GA from 24 to 27 weeks, and had birth weights of 698 to 1105 g. Given the limited GA range of these infants, further analysis of this subgroup was restricted to comparison with the 114 infants born at r27 weeks who did not develop PVL.
PVL was not more common among infants with than without either FVI (1/46 vs 4/73), hypotension on day 1 (1/36 vs 4/83) or persistent hypotension (2/37 vs 3/82). However, as compared to other infants born at or below 27 weeks gestation, infants with PVL had lower LoBP mn and LoBP dia over the first week of life than did infants without PVL (Figure2, ANOVA, p ¼ 0.0024 and 0.0056, respectively).
Ventriculomegaly without intraventricular hemorrhage was found on the cranial ultrasounds of five infants, only one of whom had been diagnosed previously with cystic PVL. Although all five infants with ventriculomegaly had pathological evidence of chorioamnionitis and two had FVI, the relationship between ventriculomegaly and placental evidence of infection was not significant. Infants with ventriculomegaly were not more likely to have had either hypotension on day 1 or persistent hypotension than were infants without ventriculomegaly.
White matter disease (PVL and/or ventriculomegaly) was not more common among infants who had both persistent hypotension and FVI (0.0%) than it was among infants with hypotension alone (8%), FVI alone (4%), or neither hypotension nor FVI (3%). In a binomial logistic regression model, neither FVI (OR 0.48, 95% CI 0.08 to 2.75, p ¼ 0.41), persistent hypotension (OR 1.52, 95% CI 0.32 to 7.21, p ¼ 0.60), nor gestational age (OR 0.70, 95% CI 0.46 to 1.07, p ¼ 0.10) predicted the occurrence of white matter disease among this cohort of very-low-birth-weight infants.
SIGNIFICANCE
We hypothesized that very-low-birth-weight infants whose placentas revealed inflammation of the fetal vessels would have lower BP over the first week of life and an increased likelihood of white matter injury than would infants without FVI. We found that BP over the first week of life was lower among very-low-birth-weight infants with FVI than without FVI when the GA was above 29 completed weeks. In these infants, FVI was associated with a 12-fold increased risk of hypotension. FVI was not associated low BP in younger infants. However, infants born at r27 weeks gestation who developed PVL had lower mean and diastolic BPs over the first week of life than did infants without PVL.
Epidemiologic studies have indicated that infants born of pregnancies complicated by chorioamnionitis are at increased risk of developing cerebral palsy. 4, 13 The risk of cerebral palsy is increased among premature newborns whose cranial ultrasound indicates the presence of PVL 14 and/or ventriculomegaly, 15 and these lesions have been reported to be more prevalent among infants whose placentas have histologic evidence of chorioamnionitis. 3, 4, 15 The mechanism by which white matter injury occurs in the setting of chorioamnionitis remains uncertain. However, evidence is accruing to implicate a role for cytokine mediated-inflammation 4, 16, 17 in the pathogenesis of what was previously considered a typical hypoxic-ischemic lesion 2, 18 It is probable that both inflammation and hypoxia-ischemia contribute to the pathogenesis of white matter injury in premature newborns.
We have demonstrated previously that infants born to mothers with chorioamnionitis had both higher cord blood concentrations of interleukin-6 and lower BP at 3±1 hour after birth, and that BP in these 56 newborns was linearly correlated with the interleukin-6 concentration. 5 The current study was designed to investigate the relationship among inflammation of the fetal vessels, BP and cranial ultrasound abnormalities in a larger population of verylow-birth-weight infants. We chose to use FVI, rather than chorioamnionitis per se, because we anticipated that this would narrow the cases to those in whom the inflammatory response was the greatest, and therefore most likely to result in altered neonatal hemodynamics.
The finding that FVI was associated with lower BP only in the oldest GA group can be explained by one of the three phenomena. First, it is possible that the control infants without FVI in the Z30 week GA stratum had higher than normal BPs. There is no evidence to support this. There were no differences between infants with and without FVI in the clinical variables most likely to be associated with altered BP (Table 1 ). There was a nonsignificant trend for more infants Z30 week GA in the control population to have received antenatal steroids. Although antenatal steroids had an independent positive effect on BP in this GA stratum, FVI had a significant negative influence on BP even in the presence of antenatal glucocorticoid. Additionally, it has been suggested that pre-eclampsia 19 increases BP in the newborn premature infant. However we excluded infants born to mothers with preeclampsia a priori because our own data confirm that they have higher BP than infants born to mothers without preeclampsia. 7 When the analysis was repeated with these infants included (data not presented), the results were unchanged, with the sole exception that the association of FVI with lower BP in the oldest GA stratum was even stronger than reported.
Next, it is possible that the vascular responsiveness to cytokines is GA-dependent, such that only the gestationally more mature very-low-birth-weight-infants become hypotensive in the presence of elevated intravascular cytokines. It has been shown that premature infants whose placentas manifest FVI and chorioamnionitis have increased circulating concentrations of the proinflammatory cytokines 5, 20 and that BP in newborn premature infants is proportional to serum interleukin-six concentration. 5 The specific relationship between GA and endovascular responsiveness to inflammatory mediators has not been described. If there were indeed a developmental threshold that must be reached before the vasculature becomes responsive to cytokines, then this would explain the absence of an effect of FVI on BP in the younger GA strata.
Finally, it is possible that FVI was associated with lower BP in the older infants and not the younger infants because alternate mechanisms of hypotension acted upon the infants in the younger GA strata. Although we looked at many clinical variables, and they were comparable between infants with and without FVI, it is possible that other unaccounted variables may have affected BP. For example, we did not evaluate factors such as thyroid function, maternal receipt of magnesium sulfate or other tocolytic agents, newborn pH, and presence of patent ductus arteriosus. Since most very-low-birth-weight infants in our unit receive indomethacin before 36 hours of age, either as prophylaxis or to close an echocardiographically open ductus arteriosus, it is unusual for us to observe a symptomatic patent ductus arteriosus that results in hypotension lasting the first week of life.
Dammann et al. 21 have looked at a comparable sample of infants at or below 28 weeks gestation and found that fetal vasculitis was more common among infants with than without cranial ultrasound echolucencies (62 vs 41%). However, after adjusting for confounders (including those not accounted for in this report), they did not find a relationship between fetal vasculitis and hypotension, nor between hypotension and echolucencies. A handful of other investigations have evaluated the relationship between BP and neurologic outcome among premature infants. [22] [23] [24] [25] [26] Whereas some have found a strong relationship, 22 ,24,25 others have not. 21, 23, 26 This investigation differs from the previous in that (a) it analyzes the distribution of BPs rather than just the lowest mean blood pressure; (b) it includes measurements obtained over a full week, rather than the first day(s) of life, and (c) it relates the BPs to a significant perinatal complication (chorioamnionitis) known to increase the risk of white matter injury, and defines a clinically significant subset of this condition (FVI) using objective pathological criteria.
There are two limitations to our investigation. First, we could not control the modality of BP measurement because of the retrospective design. However, any prospective study that includes only those infants with intra-arterial monitoring would contain ascertainment bias since indwelling catheters are only used in the sickest infants. The use of invasive intra-arterial BP monitoring solely for study purposes would be unethical. The ANOVA model that we used accounts for the BP measurement technique on each and every day, and should thereby eliminate any potential measurement bias.
The second limitation to this project is that our data regarding the use of vasopressor support is complete for only 89% of study infants. It is unlikely that the missing data would significantly affect the results. In fact, we sought to assess whether the actual BP over a prolonged period rather than the short-term use of a vasopressors agent contributed to the risk of white matter damage. Cunningham et al. 26 found that although dopamine was one of seven univariate factors to be associated with the level of mean BP in very-low-birth-weight infants in the first 7 days of life, the only factors that were important in multivariate analysis were GA, birth weight, and colloid support. Therefore, we are confident that our results are not biased by the lack of complete data regarding the use of vasopressors.
In summary, we found that among very-low-birth-weight infants born at 29 weeks gestation or after, FVI was associated with low BP over the first week of life. Infants born at lesser gestations who developed PVL had lower BPs over these 7 days than did infants without PVL. However, neither hypotension nor FVI predicted white matter injury in our cohort. We speculate that the etiology of white matter injury in premature infants born to mothers with chorioamnionitis is multifactorial with interactions between the BP, fluctuations in BP, serum and intracerebral cytokines, genetic and other factors that increase susceptibility in some infants.
